Morgan Stanley’s Circle Downgrade: The 68% Target Cut and the 470% Position Hike — A Liquidity Game
Skepticism isn’t about doubting everything. It’s about dissecting the liquidity flows.
Liquidity doesn’t lie, but institutional disclosures do — they have a time stamp. On August 3, 2025, Morgan Stanley’s research arm slashed its price target on Circle (CRCL) from $106 to $38. A 68% haircut. The rating dropped from Hold to Underweight. Then, just 12 days later, the market discovered that Morgan Stanley’s own asset management division had increased its CRCL stake by 470% in Q2, holding 8.3 million shares. The narrative writes itself: “Wall Street hypocrisy.”
Except that’s lazy. The real story is about time, liquidity, and the structural decoupling between research and capital allocation.
Context: Circle is the issuer of USDC, the second-largest dollar-pegged stablecoin. USDC is a regulated, transparent, institution-friendly asset. But its business model is simple: earn interest on the dollar reserves backing USDC. That’s it. When the Fed cuts rates, Circle’s revenue shrinks. When USDC circulation drops, the reserve base shrinks. Double whammy. The downgrade cited exactly that: “Lower USDC circulation and a shift to lower-margin revenue models.”
Core: Let’s map the liquidity chain. USDC circulation peaked in early 2025 and has been contracting. The 13F filing covers the period April to June — before the worst of the circulation data. By August, the research team had updated their models. They cut their 2027 USDC circulation estimate by 33%, and 2028 by 44%. That’s not a tweak. That’s a structural re-rating.
Now, the target price. $106 to $38 implies a 64% drop. But the EPS cuts were only 3% for 2027 and 20% for 2028 relative to consensus. The math doesn’t align unless you assume a compression in valuation multiples. In my years auditing whitepapers and mapping liquidity cycles, I’ve learned that when a target cut outpaces earnings revisions by 3x, the analyst is signaling a sector de-rating, not just a company-specific issue. They’re saying: “Stablecoin issuers are not growth tech. They are interest-rate-sensitive infrastructure.”
Contrarian: The popular narrative — “Morgan Stanley talked their book” — is a trap. The 13F increase is not a “brotherhood of conviction.” It’s the asset management division making a separate bet, likely driven by passive index rebalancing or a macro hedge. The Chinese wall between research and trading exists for a reason. More importantly, the 470% increase could be a rounding error in a multi-billion-dollar portfolio. The real signal is the downgrade, because it’s forward-looking.
But here’s the blind spot the market misses: The downgrade may be pricing in a future where U.S. stablecoin legislation allows banks to issue their own dollar tokens. If that happens, Circle’s regulatory moat dissolves. The 13F purchase, on the other hand, might be a play on the current regulatory tailwind — a short-term trade. The two positions are not contradictory; they operate on different time horizons.
Liquidity doesn’t care about your narrative. It follows the path of least resistance. Right now, USDC circulation is down, and the Fed is cutting rates. Circle’s revenue is under pressure. The $38 target may be conservative if circulation continues to slide.
Takeaway: The market’s obsession with the “13F vs. downgrade” contradiction is a distraction. The real question is: Will USDC circulation recover? Watch Q3 circulation data and the next 13F. If Morgan Stanley’s asset management trims their position, that’s your confirmation. If they hold, it’s still a hedge. The downgrade is the signal. The 13F is noise with a 45-day delay.